Genscript Biotech Corporation (GNNSF)
OTCMKTS · Delayed Price · Currency is USD
2.190
-0.010 (-0.45%)
Sep 4, 2025, 8:00 PM EDT
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of $5.07 billion as of September 8, 2025. Its market cap has increased by 47.63% in one year.
Market Cap
5.07B
Enterprise Value
4.68B
Revenue
828.10M
Ranking
n/a
PE Ratio
1.63
Stock Price
$2.19
Market Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 272.50M to 5.07B, an increase of 1,760.49%. That is a compound annual growth rate of 35.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 5.07B | 86.66% |
| Dec 31, 2024 | 2.72B | -49.68% |
| Dec 29, 2023 | 5.40B | -19.93% |
| Dec 30, 2022 | 6.74B | -27.50% |
| Dec 31, 2021 | 9.30B | 227.16% |
| Dec 31, 2020 | 2.84B | -33.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 749.52M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.00M |
| HealthLynked | 499.79M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |